About SynapCon :

Wouldn’t you just like to be able to evaluate the input data of all your projects 24/7,
use visualisation and artificial intelligence to make informed decisions and interact with the authorities to accelerate your time to market?

Our Story :

Founded in May 2021, SynapCon(c) GmbH develops advanced technologies and business models with a clear focus on accelerating the clinical development of drugs and medical devices, making products available to patients more quickly and reducing the burden on healthcare systems in the long term. Thanks to the recent notice to sponsors from the EMA our product has never seen a better time to show off its capabilities.

In 2005 our CEO was a managing director of the CRO he founded. During that time, he held a responsible position by the Jerini Ag and contributed in the clinical development of a drug against the rare disease of hereditary angioedema. Even after the takeover of Jerini by Shire Ltd., he was responsible as project manager for the further projects up to FDA approval. The CTM system EasyClin(c) which he had developed, was used in two global studies. Thanks to this new, oustanding system, he was able to keep the calculated time and cost framework at 100%. The system then got validated in 2010 according to 21 CFR part 11. Moreover, it got approved by the client and accepted by the FDA. While studies usually lead to long delays and  high costs due to manual post-proccessing, it can now be avoided with the use of our systems. At peak times, up to 250 users worldwide (doctors, laboratories, CRAs, etc:) at the same time use one single installation.

Based on these experiences and the knowledge generated, a new development funded by the European Union was created from 2017 onwards. It implements the latest findings and requierements in IT and regulations as standards. Since 2021, the new systems are available and successfully in use to the full satisfaction of customers.

Our Vision :

It is our vision to bring innovative medical products to patients faster and alleviate suffering, by shortening clinical development times, through faster processes in the clinical research world.

Purpose & Benefit :

A digital health approach that makes a difference for all stakeholders (including patients, doctors & payers), through IT powered management of drug and medical device development. It is our vision to innovate the clinical trials world through disrupting outdated processes and organizational structures.

Our innovative solutions optimize the interface between patient data, clinics and the industry that develops drugs and medical devices. This includes the implementation of our digital solutions and coordinated consulting to optimize proscesses. 

We have market knowledge of the entire medical value chain. Our goal is to provide our customers with profitable advantages from the current challenges of the market. Our commitment and technical expertise helps shorten development cycles to ensure faster patient care and reduce development costs to make innovative medicines affordable.

Meet the Team :

SynapCon is managed by a highly experienced team,
with offices throughout Europe and a global network of clients.

Sven
Engel
Sven Engel
CEO, CIO & Founder
Biotechnologist, Clinical Researcher, 20 years of entrepreneurial experience. Deep insight in the whole value chain of bio-pharmaceutical and medical product development and organisation. Software developer. Visionary and strategic thinker with the power to translate knowledge and information into products.
Alexander
Hopman
Alexander Hopman
COO, CMO
Seasoned medical and online professional with a broad international background. 25+ years of experience in medicine, digital marketing and web portals. Started several own companies, including the award-winning #1 chatbot in German healthcare. Passionate blockchain and NFT evangelist, extremely well-connected in both the German and Swiss philanthropic and startup ecosystem, always fostering our core value: Innovation for a better and brighter future for all of mankind.
Holger
Fuhrmann
Holger Fuhrmann
Management
Head Talent Acquisition & Development MBA & Business Coach Special Fields: HR Recruitment & Development in Life Science since 2000, Employer Branding, New Work.
Alexander
Gisdakis
Alexander Gisdakis
Management
CEO Breitenstein Consulting GmbH & Co. KG, coach, mediator, human resources manager, special fields: Human resources, management development, organizational development.
René
Seiler
René Seiler
Corporate Development
Dipl. Betriebswirt, special fields: Corporate strategy & cooperation, marketing & sales, investor search.
Tim
Bookas
Tim Bookas
Management
CEO Breitenstein Consulting GmbH & Co. KG, coach, mediator, human resources manager, special fields: Human resources, management development, organizational development.
Linda
Frahnke
Linda Frahnke
Working Student
Sven Engel ›
Alexander Hopman ›
Biotechnologist, Clinical Researcher, 20 years of entrepreneurial experience, deep insight in the whole calue chain of bio-pharmaceutical and medical product development, organisation and software developer, visionary and strategic thinking with the power to translate knowledge and information into products.
Seasoned medical and online professional with a broad international background. 25+ years of experience in medicine, digital marketing and web portals. Started several own companies, including the award-winning #1 chatbot in German healthcare. Passionate blockchain and NFT evangelist, extremely well-connected in both the German and Swiss philanthropic and startup ecosystem, always fostering our core value: Innovation for a better and brighter future for all of mankind.
Holger Fuhrmann ›
Alexander Gisdakis ›
Head Talent Acquisition & Development, MBA (International Marketing) & Business Coach (DBVC), 17 years' experience in the search, selection and development of specialist and executive staff in the life science industry, Founder and CEO of PHARECON (executive search company with life science focus in Europe).
CEO Breitenstein Consulting GmbH & Co. KG, coach, mediator, human resources manager, special fields: Human resources, management development, organizational development.
René Seiler ›
Tim Bookas ›
Dipl. Betriebswirt, special fields: Corporate strategy & cooperation, marketing & sales, investor search.
CEO Breitenstein Consulting GmbH & Co. KG, coach, mediator, human resources manager, special fields: Human resources, management development, organizational development.
Linda Frahnke ›
Working Student at SynapCon GmbH